Advanced Viral Research announces publication of Dr. Shalom Z. Hirschman's paper.HALLANDALE, Fla.--(BUSINESS WIRE)--July 11, 1996--Advanced Viral Research Corp. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:ADVR) is pleased to announce that it has been informed by Dr. Shalom Hirschman that the paper entitled "Peptide Nucleic Acids Stimulate Gamma Interferon and Inhibit The Replication of the Human Immunodeficiency Virus human immunodeficiency virus n. HIV. Human immunodeficiency virus (HIV) A transmissible retrovirus that causes AIDS in humans. ," by Dr. Shalom Z. Hirschman, M.D., professor of Medicine and director of the Division of Infectious Diseases of the Mount Sinai School of Medicine
Mount Sinai School of Medicine is a medical school found in the borough of Manhattan in New York City. in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. , has been accepted for publication on Aug. 17, 1996 in the Journal of Investigative Medicine, "The Official Publication of the American Federation for Clinical Research." According to Dr. Hirschman: "Although its acceptance and publication may have become public knowledge, the contents of the paper itself remain highly confidential. In fact, the paper may not be publicly released until its date of publication by the American Federation for Clinical Research in the Aug. 27, 1996 issue of the Journal of Investigative Medicine." Dr. Hirschman is able to report Reticulose, inhibits the replication of the human immunodeficiency virus (HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. ) in cell culture systems. Further, Reticulose stimulates production of a unique set of Chemokines, including Interleukin 6 and Gamma Interferon. Dr. Hirschman has reported that stimulation of Chemokine chemokine /che·mo·kine/ (ke´mo-kin) any of a group of low molecular weight cytokines identified on the basis of their ability to induce chemotaxis or chemokinesis in leukocytes (or in particular populations of leukocytes) in inflammation. production by Reticulose may account, at least in part, for the previous reported clinical efficacy of Reticulose in treating several viral diseases. The cost of the study of Reticulose by Dr. Hirschman of the Mount Sinai School of Medicine in New York City was funded by Advanced Viral Research Corp. Reticulose is a non-toxic antiviral peptide nucleic acid preparation by Advanced Viral Research Corp. which, based on previous history, has been shown to be effective against a number of viral diseases. CONTACT: Advanced Viral Research Corp., Hallandale William Bregman, 954/458-7636 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion